More or less: Copy number alterations in mycosis fungoides

Journal of Investigative Dermatology

Volumn 130, Issue 4, 2010, Pages 926-928

  Lin, William M ^a   Girardi, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; TUMOR SUPPRESSOR PROTEIN;

CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; MYCOSIS FUNGOIDES; NOTE; PRIORITY JOURNAL; PROGNOSIS; SKIN CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

EID: 77949524082     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.370     Document Type: Note

References (13)

1. Aguilera A, Gómez-González B (2008) Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 9:204-217
2. Carbone A, Bernardini L, Valenzano F et al. (2008) Array-based comparative genomic hybridization in early-stage mycosis ungoides: recurrent deletion of tumor uppressor genes BCL7A, SMAC/DIABLO, and RHOF. Genes Chromosomes Cancer 47:1067-1075
3. Fischer TC, Gellrich S, Muche JM et al. (2004) Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol 122:579-586
4. Gallardo F, Esteller M, Pujol RM et al. (2004) Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas. Haematologica 89:1401-1403
5. Karenko L, Hahtola S, Ranki A (2007) Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL). Cytogenet Genome Res 118:353-361
6. Lin WM, Baker AC, Beroukhim R et al. (2008) Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 68:664-673
7. Mao X, Lillington D, Scarisbrick JJ et al. (2002) Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides. Br J Dermatol 147:464-475
8. Navas IC, Ortiz-Romero PL, Villuendas R et al. (2000) p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 156:1565-1572
9. Prochazkova M, Chevret E, Mainhaguiet G et al. (2007) Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer 46:828-838
10. Salgado R, Servitje O, Gallardo F et al. (2010) Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J Invest Dermatol 130:1126-1135
11. Vermeer MH, van Doorn R, Dijkman R et al. (2008) Novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 68:2689-2698
12. van Doorn R, van Kester MS, Dijkman R et al. (2009) Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113:127-136
13. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789-799